Analysis of a tissue microarray (TMA) containing samples from 75 breast cancer patients, with different tumor stages but unspecified subtype, showed that Insulin/IGF-1R signaling was activated in 56 of 75 (~ 75%) patients (Fig. 1e and Supplementary Table. The gene discussed is INS; the disease is breast carcinoma.